How many studies have been conducted on Alefacept?

BiohacksAI has indexed 297 PubMed studies on Alefacept, including 38 randomized controlled trials (RCTs). 73% of studies involve human subjects.

What are the main research areas for Alefacept?

The primary research domains for Alefacept are ✨ Skin & Hair, 🛡️ Immunity, 🔬 Oncology. This is based on analysis of 297 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Alefacept

A recombinant human fusion protein of LFA-3 antigen and immunoglobulin IGG1 that binds to CD2 ANTIGENS on memory T-LYMPHOCYTES, preventing their activation and proliferation. It is used in the management of moderate to severe chronic plaque PSORIASIS.

297+ PubMed studies analyzed · 38 RCTs · Evidence Score: 56.6

Research Domains

Alefacept has been studied across 10 research domains including ✨ Skin & Hair, 🛡️ Immunity, 🔬 Oncology, 🔬 Inflammation, 🦴 Bone & Joint. The primary research focus is ✨ Skin & Hair with 66% of studies addressing this area.

Loading evidence profile...

This evidence profile for Alefacept is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.